| pubmed-article:19208349 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19208349 | lifeskim:mentions | umls-concept:C0019196 | lld:lifeskim |
| pubmed-article:19208349 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19208349 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19208349 | lifeskim:mentions | umls-concept:C0002199 | lld:lifeskim |
| pubmed-article:19208349 | lifeskim:mentions | umls-concept:C0035525 | lld:lifeskim |
| pubmed-article:19208349 | lifeskim:mentions | umls-concept:C0796545 | lld:lifeskim |
| pubmed-article:19208349 | lifeskim:mentions | umls-concept:C0231175 | lld:lifeskim |
| pubmed-article:19208349 | lifeskim:mentions | umls-concept:C1704419 | lld:lifeskim |
| pubmed-article:19208349 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19208349 | pubmed:dateCreated | 2009-5-4 | lld:pubmed |
| pubmed-article:19208349 | pubmed:abstractText | Treatment with peginterferon alfa and ribavirin produces a sustained virologic response (SVR) in approximately 60% of hepatitis C virus (HCV)-infected patients. Alternate options are needed for patients who relapse or do not respond to therapy. | lld:pubmed |
| pubmed-article:19208349 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19208349 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19208349 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19208349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19208349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19208349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19208349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19208349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19208349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19208349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19208349 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19208349 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19208349 | pubmed:month | May | lld:pubmed |
| pubmed-article:19208349 | pubmed:issn | 1528-0012 | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:HeathcoteE... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:ColomboMassim... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:PoynardThierr... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:BruixJordiJ | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:BedossaPierre... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:BergThomasT | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:Moreno-OteroR... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:AlbrechtJanic... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:SilvaMarceloM | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:SchiffEugeneE | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:DiagoMoisesM | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:CraxiAntonioA | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:FlammStevenS | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:BrassClifford... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:TergRubenR | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:MukhopadhyayP... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:SchmidtWarren... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:McGarrityThom... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:CarrilhoFlair... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:GonçalesFerna... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:GriffelLouisL | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:BurroughsMarg... | lld:pubmed |
| pubmed-article:19208349 | pubmed:author | pubmed-author:Epic Study... | lld:pubmed |
| pubmed-article:19208349 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19208349 | pubmed:volume | 136 | lld:pubmed |
| pubmed-article:19208349 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19208349 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19208349 | pubmed:pagination | 1618-28.e2 | lld:pubmed |
| pubmed-article:19208349 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:meshHeading | pubmed-meshheading:19208349... | lld:pubmed |
| pubmed-article:19208349 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19208349 | pubmed:articleTitle | Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy. | lld:pubmed |
| pubmed-article:19208349 | pubmed:affiliation | Service d'hepatologie, Université Pierre et Marie Curie Liver Center, Hôpital La Pitié Salpêtrière, Paris, France. tpoynard@teaser.fr | lld:pubmed |
| pubmed-article:19208349 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19208349 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:19208349 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19208349 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19208349 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19208349 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19208349 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19208349 | lld:pubmed |
